James Xue is the founder of CANbridge Pharmaceuticals. CANbridge Pharmaceuticals has raised $141M in total funding. Latest round: Series E.
James Xue, PhD, is the Founder, Chairman, and CEO of CANbridge Pharmaceuticals. He has expressed gratitude for investor enthusiasm and highlighted the company's achievements, including strengthening operating capabilities and achieving marketing approvals.
Full founder directory · Investor directory · Company funding database · Fundraising library